Key result
Depressive symptoms at dialysis start linked to ~43% higher cardiovascular mortality.
Why the study?
Do depressive symptoms increase cardiovascular and noncardiovascular mortality in patients with end-stage renal disease starting on dialysis?
Cohort (n=1,528)
Yes
Do depressive symptoms increase cardiovascular and noncardiovascular mortality in patients with end-stage renal disease starting on dialysis?
Hazard Ratio: 1.43 (95% CI 1.08–1.88)
Depressive symptoms at the start of dialysis are a strong risk factor for both cardiovascular and noncardiovascular mortality, with varying effects over time.
Depressive symptoms may flag higher mortality risk in new dialysis patients; leaves open whether screening or treatment improves outcomes.
In Brief Objective Depressive symptoms seem to pose a risk factor for mortality among patients on dialysis. It is currently unknown whether the association is only short-lived and whether associations over time depend on specific causes of mortality. Methods In a prospective nationwide cohort study, 1528 patients with end-stage renal disease starting on dialysis completed the Mental Health Inventory. Patients were observed up to 5 years or until the end of follow-up in April 2011. Cox regression analyses were used to calculate associations between depressive symptoms and short-term (0–6 months), medium-term (6–24 months), or long-term (24–60 months) cardiovascular and noncardiovascular mortality. Results The adjusted hazard ratio (HR) was 1.43 (95% confidence interval [CI] = 1.08–1.88) for cardiovascular mortality and 2.07 (95% CI = 1.62–2.64) for noncardiovascular mortality. Depressive symptoms posed a strong risk factor for noncardiovascular mortality at the short term (HR = 2.82, 95% CI = 1.58–5.05), medium term (HR = 2.08, 95% CI = 1.40–3.09), and long term (HR = 1.84, 95% CI = 1.26–2.69), whereas the association between depressive symptoms and cardiovascular mortality was not observed during the first 6 months of follow-up (HR = 1.03, 95% CI = 0.49–2.15). Conclusions Depressive symptoms at the start of dialysis therapy are associated with short-, medium-, and long-term mortality. The cause-specific mortality risk over time may help clinicians to understand multifactorial causes of the association between depressive symptoms and survival. Abbreviations ESRD = end-stage renal disease HD = hemodialysis PD = peritoneal dialysis HR = hazard ratio CI = confidence interval NECOSAD = The Netherlands Co-operative Study on the Adequacy of Dialysis rGFR = residual glomerular filtration rate iPTH = intact parathyroid hormone CRP = C-reactive protein Supplemental digital content is available in the article.
No takes yet. Share an insight, caveat, or question.
Dijk et al. (2012) conducted a cohort in End-stage renal disease on dialysis (n=1,528). Depressive symptoms vs. Absence of depressive symptoms was evaluated on Cardiovascular mortality (HR 1.43, 95% CI 1.08-1.88). Depressive symptoms at the start of dialysis were associated with increased cardiovascular mortality (HR 1.43; 95% CI 1.08-1.88) and noncardiovascular mortality (HR 2.07; 95% CI 1.62-2.64).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: